Micafungin antifungal prophylaxis in children undergoing HSCT: can we give higher doses, less frequently? A pharmacokinetic study

The Journal of Antimicrobial Chemotherapy
Sharat ChandraParinda Mehta

Abstract

Micafungin has a distinct advantage for antifungal prophylaxis in HSCT owing to its better safety profile, specifically in terms of hepatic and renal toxicity. In children, prophylactic micafungin is given as either 1 mg/kg every day or 3 mg/kg every other day. We performed a prospective single-centre observational study that investigated the pharmacokinetics (PK) of a single 5 mg/kg dose of micafungin in young children undergoing HSCT, to ascertain the eventual feasibility of twice-weekly prophylactic administration. Nine children, ≤10 years of age undergoing HSCT, were enrolled and received a single intravenous dose of 5 mg/kg micafungin. Blood samples were obtained for PK analysis. Micafungin plasma concentration of >0.2 mg/L was chosen for target attainment (i.e. considered adequate prophylactic concentration). In addition, a population PK model was developed based on current and our previous PK study data. We also evaluated PK model-based simulation of PK profiles and target attainment using Monte Carlo simulation, for several dosing scenarios. Mean clearance was 15.3 mL/h/kg (range 11.0-21.4 mL/h/kg) and the mean elimination half-life was 11.6 h (range 7.8-16.6 h). The mean concentration at 96 h was 0.11 mg/L (range 0.03-...Continue Reading

References

Oct 19, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·S AbbasiP M Flynn
Sep 12, 2000·The Journal of Antimicrobial Chemotherapy·H MikamoT Tamaya
Nov 19, 2002·Antimicrobial Agents and Chemotherapy·Erika J ErnstMichael E Klepser
Nov 17, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jo-Anne H van BurikUNKNOWN National Institute of Allergy and Infectious Diseases Mycoses Study Group
Jul 29, 2005·Antimicrobial Agents and Chemotherapy·Nita L SeibelThomas J Walsh
Jan 24, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Arlo UptonKieren A Marr
Jul 20, 2007·Antimicrobial Agents and Chemotherapy·William W HopeThomas J Walsh
Oct 5, 2007·Annual Review of Pharmacology and Toxicology·B J Anderson, N H G Holford
Nov 6, 2007·British Journal of Haematology·Penelope D Barnes, Kieren A Marr
Aug 19, 2009·Antimicrobial Agents and Chemotherapy·Jun IshikawaYuzuru Kanakura
Sep 15, 2009·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Marcie TomblynUNKNOWN Centers for Disease Control and Prevention
Mar 24, 2010·Antimicrobial Agents and Chemotherapy·William W HopeDaniel K Benjamin
Jun 16, 2010·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Parinda A MehtaStella M Davies
Dec 14, 2011·Journal of Clinical Pharmacology·Yaning WangJogarao V Gobburu
Feb 4, 2012·The Pediatric Infectious Disease Journal·Nasrullah A UndreAntonio Arrieta
Aug 24, 2012·Expert Opinion on Drug Safety·Corrado Girmenia, Anna Paola Iori
Jul 10, 2013·CPT: Pharmacometrics & Systems Pharmacology·R J KeizerA Hooker
Nov 26, 2014·Antimicrobial Agents and Chemotherapy·William W HopeDaniel K Benjamin
Jan 8, 2015·The Journal of Antimicrobial Chemotherapy·K BochennekT Lehrnbecher
Nov 15, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Dionysis NeofytosGenovefa Papanicolaou
May 30, 2017·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Nick H G Holford, Brian J Anderson

❮ Previous
Next ❯

Citations

Jan 25, 2020·Paediatric Drugs·Kevin J DownesNicole R Zane
Dec 23, 2021·Internal Medicine Journal·Benjamin W TehUNKNOWN Australasian Antifungal Guidelines Steering Committee

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

© 2022 Meta ULC. All rights reserved